These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25040564)

  • 1. Intestinal metaplasia in Barrett's oesophagus may be an epiphenomenon rather than a preneoplastic condition, and CDX2-positive cardiac-type epithelium is associated with minute Barrett's tumour.
    Watanabe G; Ajioka Y; Takeuchi M; Annenkov A; Kato T; Watanabe K; Tani Y; Ikegami K; Yokota Y; Fukuda M
    Histopathology; 2015 Jan; 66(2):201-14. PubMed ID: 25040564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells?
    Kerkhof M; Bax DA; Moons LM; van Vuuren AJ; van Dekken H; Steyerberg EW; Kuipers EJ; Kusters JG; Siersema PD;
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1613-21. PubMed ID: 17206949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
    Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S
    World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
    Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
    Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
    Phillips RW; Frierson HF; Moskaluk CA
    Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma--a possible biomarker to predict the malignant potential of Barrett's oesophagus.
    Iwaya Y; Hasebe O; Koide N; Kitahara K; Suga T; Shinji A; Muraki T; Yokosawa S; Yamada S; Arakura N; Tanaka E; Nakayama J
    Histopathology; 2014 Mar; 64(4):536-46. PubMed ID: 24117499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry for CDX2 expression in non-goblet-cell Barrett's oesophagus.
    Behan M; Gledhill A; Hayes S
    Br J Biomed Sci; 2014; 71(2):86-92. PubMed ID: 24974686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDX2 and LI-cadherin expression in esophageal mucosa: use of both markers can facilitate the histologic diagnosis of Barrett's esophagus and carcinoma.
    Weimann A; Zimmermann M; Gross M; Slevogt H; Rieger A; Morawietz L
    Int J Surg Pathol; 2010 Oct; 18(5):330-7. PubMed ID: 20444732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of Barrett's oesophagus.
    Van Eyken P
    Acta Gastroenterol Belg; 2000; 63(1):10-2. PubMed ID: 10907312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium.
    Kazumori H; Ishihara S; Rumi MA; Kadowaki Y; Kinoshita Y
    Gut; 2006 Jan; 55(1):16-25. PubMed ID: 16118348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.
    Vallböhmer D; DeMeester SR; Peters JH; Oh DS; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; DeMeester TR; Chandrasoma PT
    Dis Esophagus; 2006; 19(4):260-6. PubMed ID: 16866857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
    Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
    Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development.
    Kazumori H; Ishihara S; Kinoshita Y
    Gut; 2009 May; 58(5):620-8. PubMed ID: 19136512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
    Schilling D; Spiethoff A; Rosenbaum A; Hartmann D; Eickhoff A; Jakobs R; Weickert U; Rebe M; Bohrer MH; Riemann JF
    Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.
    Groisman GM; Amar M; Meir A
    Mod Pathol; 2004 Oct; 17(10):1282-8. PubMed ID: 15167938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.
    Villanacci V; Rossi E; Zambelli C; Galletti A; Cestari R; Missale G; Casa DD; Bassotti G
    Dig Liver Dis; 2007 Apr; 39(4):305-11. PubMed ID: 17307036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.
    Pascarenco OD; Boeriu A; Mocan S; Pascarenco G; Drasoveanu S; Galeanu M; Dobru D
    J Gastrointestin Liver Dis; 2014 Mar; 23(1):19-25. PubMed ID: 24689092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
    Chinyama CN; Marshall RE; Owen WJ; Mason RC; Kothari D; Wilkinson ML; Sanderson JD
    Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.